Frequency signs $80 million deal with Astellas Pharma - STAT

Frequency signs $80 million deal with Astellas Pharma - STAT

More reads

• Big Pharma’s first female CEO disrupts Glaxo from within. (Bloomberg)
• An experimental AI system can predict when pancreatic cysts will become cancerous. (STAT)
• Frequency signs $80 million deal with Astellas Pharma. (STAT Plus)